At the time that Cellceutix, first made the overture toward retinoblastoma, I construed that the Kevetrin compound was both safe and very effective. Why? Because I believed that I knew something about the character of the key people within the company and also at Dana Farber. I sincerely believed that toddlers and children were far to precious for them to conduct a medical experiment upon unless they had every reason to believe that they would in significant part succeed. You can take the preceeding statement, multiply it x 10 and place the names that you know from both Cellceutix and Dana Farber next to it for emphasis.
Now the FDA has weighed in. Remember that a mother named Dr. Margaret Hamburg was Head of the FDA during that time of record. Mothers and Grandma's, especially those with PHD's in the life sciences do not play around with face altering, life threatening diseases that effect babies and small children. From my view, the men within Cellceutix, know what it is to be a caring father.
I clearly remember having a conversation within the Seeking Alpha messaging center with a key CTIX shareholder and expressing the above viewpoint to her. So thanks to the IHUB board and aka Big Kahuna for exhuming and elucidating this salient point.
BigKahuna  | Tuesday, 12/01/15 02:12:48 PM | |
| Re: grizzlyman post# 131785 | ||
| Post # of 131865 | ||
No, it has value right now in sweetening the pot for a partner who might get the voucher in return for a large upfront payment plus big milestone payments. Also, not 4 years. Retinoblastoma is a critical unmet need and will be expedited at every level, including clinical testing. If Kevetrin is the least bit effective at the current established safe dose, it could be approved in less than 2 years. Remember, "think of the children."
Ella Ruth Below
There would be no better corporate image than Johnson and Johnson (JNJ) to partner with Cellceutix. Think of the pictures of mothers, babies and children on their healthcare products. The intangible value of a safe effective treatment for Retinoblastoma would be mind boggling for JNJ's image alone.
,
By the way, I think that Cellceutix, case is going to a female judge on Dec 18th. Happy Hanukkah/Merry Christmas Mr Rosen, you might want to share with her, why Cellceutix' compounds are of no to little value? It appears as though the FDA has recently sent a few messages ahead of this meeting. Dink Dink Dink!
I repeat, that Kevetrin will be part of the answer to millions of peoples prayers.
What A Wonderful Holyday Present This Is!
Ella Ruth